Mirant els núvols

Un equip de la Universitat de Girona observa de manera sistemàtica els núvols que passen damunt de la ciutat. Els núvols són un element de gran transcendència en la predicció del clima, tot i que encara són molt desconeguts

Projectes d’adaptació a la nova normativa de benestar animal per a truges reproductores en una explotació situada al T.M. de Les Masies de Voltragà (Osona)

El present projecte pretén reformar les naus de gestació d’una explotació de porcí blanc de cicle tancat, per tal de complir amb el Reial Decret 1135/2002 sobre “Benestar animal en les explotacions porcines”

An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: gefitinib (Iressatrade mark)-induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review)

Intrinsic resistance to the epidermal growth factor receptor (EGFR; HER1) tyrosine kinase inhibitor (TKI) gefitinib, and more generally to EGFR TKIs, is a common phenomenon in breast cancer. The availability of molecular criteria for predicting sensitivity to EGFR-TKIs is, therefore, the most relevant issue for their correct use and for planning future research. Though it appears that in non-small-cell lung cancer (NSCLC) response to gefitinib is directly related to the occurrence of specific mutations in the EGFR TK domain, breast cancer patients cannot be selected for treatment with gefitinib on the same basis as such EGFR mutations have been reported neither in primary breast carcinomas nor in several breast cancer cell lines. Alternatively, there is a general agreement on the hypothesis that the occurrence of molecular alterations that activate transduction pathways downstream of EGFR (i.e., MEK1/MEK2 - ERK1/2 MAPK and PI-3'K - AKT growth/survival signaling cascades) significantly affect the response to EGFR TKIs in breast carcinomas. However, there are no studies so far addressing a role of EGF-related ligands as intrinsic breast cancer cell modulators of EGFR TKI efficacy. We recently monitored gene expression profiles and sub-cellular localization of HER-1/-2/-3/-4 related ligands (i.e., EGF, amphiregulin, transforming growth factor-α, ß-cellulin, epiregulin and neuregulins) prior to and after gefitinib treatment in a panel of human breast cancer cell lines. First, gefitinibinduced changes in the endogenous levels of EGF-related ligands correlated with the natural degree of breast cancer cell sensitivity to gefitinib. While breast cancer cells intrinsically resistant to gefitinib (IC50 ≥15 μM) markedly up-regulated (up to 600 times) the expression of genes codifying for HERspecific ligands, a significant down-regulation (up to 106 times) of HER ligand gene transcription was found in breast cancer cells intrinsically sensitive to gefitinib (IC50 ≤1 μM). Second, loss of HER1 function differentially regulated the nuclear trafficking of HER-related ligands. While gefitinib treatment induced an active import and nuclear accumulation of the HER ligand NRG in intrinsically gefitinib-resistant breast cancer cells, an active export and nuclear loss of NRG was observed in intrinsically gefitinib-sensitive breast cancer cells. In summary, through in vitro and pharmacodynamic studies we have learned that, besides mutations in the HER1 gene, oncogenic changes downstream of HER1 are the key players regulating gefitinib efficacy in breast cancer cells. It now appears that pharmacological inhibition of HER1 function also leads to striking changes in both the gene expression and the nucleo-cytoplasmic trafficking of HER-specific ligands, and that this response correlates with the intrinsic degree of breast cancer sensitivity to the EGFR TKI gefitinib. The relevance of this previously unrecognized intracrine feedback to gefitinib warrants further studies as cancer cells could bypass the antiproliferative effects of HER1-targeted therapeutics without a need for the overexpression and/or activation of other HER family members and/or the activation of HER-driven downstream signaling cascades

Geografía, ordenación del territorio y colonialismo español en Marruecos

L’inici de la experiència colonial espanyola en Àfrica del Nord va suposar per a la geografia l’ocasió de fer-se sentir per mitjà de la creació d’institucions i de la realització de treballs científics adreçats a donar a conèixer la importància de la presència en Marroc a una població traumatitzada per la pèrdua recent del que quedava d’un imperi colonial abans extens. Els avatars de la implantació del Protectorat espanyol van retardar la implantació l’una vertadera política colonitzadora, que va ser possible fins després de la Guerra Civil. L’africanisme dels militars, entre ells el General Franco, explica que durant la dècada dels 40 sorgiren projectes d’ordenació del territori que van tenir un caràcter pioner a l’Espanya de la postguerra, però que van ser, una vitrina de propaganda del nou règim. En aquella època, però, la geografia espanyola es va mostrar incapaç de participar en aquesta experiència a causa del seu retard institucional i acadèmic, i el domini de la ordenació del territori va quedar en mans d’altres professionals que tenien els coneixements que els faltaven als geògrafs

Towards closure between measured and modelled UV under clear skies at four diverse sites

The purpose of this work is determine the extent of closure between measurements and models of UV irradiances at diverse sites using state of the art instruments, models, and the best available data as inputs to the models. These include information about aerosol optical depth (unfortunately not extending down as far into the UVB region as desirable because such information is not generally available), ozone column amounts, as well as vertical profiles of temperature. We concentrate on clear-sky irradiances, and report the results in terms of UV Index (UVI)